Table of Contents
Materials and general experimental methods 2 Development of a genetic system for Streptomyces sp. YIM56141 2 Cloning, sequencing, and annotation of the chx gene cluster 3 λ-RED mediated gene inactivation and mutant complementation 3 HPLC analysis of fermentation extracts 4 Isolation of dehydrocycloheximide (10) 4 Cloning and expression of chxH and overproduction and purification of ChxH 4 In vitro assay and kinetic analysis of ChxH activity 5 References 5  Table S1 Summary of primers used in this study 6  Table S2 Summary of plasmids and strains used in this study 7 Table S3 Deduced functions of the genes within the chx cluster 8 Table S4 1 H (500 MHz) and 13 C (125 MHz) NMR data of 10 in CDCl 3 8 Table S5 Summary of the apparent kinetic parameters for ChxH 9 Figure 
Materials and general experimental methods
Bacterial strains, plasmids, and media. Escherichia coli DH5α was used for routine cloning, E. coli XL1 Blue MR and Gigapack III XL (Stratagene, La Jolla, CA) for genomic library construction, E. coli BW25113/pIJ790 for PCR-targeting and λ-RED-mediated mutagenesis, 1 E. coli ET12567/pUZ8002 2 for E. coli-Streptomyces sp. YIM56141 conjugation, and E. coli BL21(DE3) for heterologous expression. S. sp. YIM56141 has been described previously. 3 The pGEM-T easy vector (Promega, Madison, WI), SuperCos1 (Stratagene, La Jolla, CA), and pUC18 (Thermo-Fisher Scientific, Pittsburgh, PA) were from commercial sources. The plasmids pIJ773, 1 pIJ790, 1 pBS3080, 4 and pBS9010 5 were described previously. All other plasmids and strains used in this study are summarized in Table S2 . Ampicillin (100 μg/ml), apramycin (50 μg/ml), and chloramphenicol (25 μg/ml) were used for selection in E. coli. Apramycin (50 μg/ml) and kanamycin (200 μg/ml) were used for selection of S. sp. YIM56141 recombinants. Trimethoprim (50 μg/ml) was used to select against the E. coli conjugal donors after E. coli-S. sp YIM56141 conjugation. S. sp. YIM56141 wild-type and mutant strains were routinely grown at 28°C in TSB liquid medium. ISP4 solid medium was used to prepare spores, and IWL4 solid medium (ISP4 medium supplemented with 0.05% yeast extract, 0.1% tryptone, and MgCl 2 to a final concentration of 20 mM) was used to plate out conjugation mixtures. For cycloheximide (1), actiphenol (2) and congener production, fresh spores of S. sp. YIM56141 and recombinant strains were cultured in 250-ml baffled flasks containing 50 ml of TSB medium for 40 hrs at 28°C and 250 rpm. Then, 0.5 ml of the seed cultures were inoculated into 250-ml baffled flasks containing 50 ml of the production medium (malt extract 5.0 g, dextrose 2.0 g, yeast extract 2.0 g, pH 7.0) and fermented at 28°C, 250 rpm for 5 days.
Instrumentation. Unless otherwise noted, PCR experiments were performed with LA Taq polymerase (Takara Bio Inc, Shiga, Japan) and run in an Eppendorf Gradient Thermocycler (Brinkman Instruments, Westbury, NY). High performance liquid chromatography (HPLC) was performed with an Apollo C18 column (5 μm, 4.6 x 250 mm; Grace Davison Discovery Sciences, Deerfield, IL) (analytical) or an Alltima C18 column (5 μm, 10 x 250 mm; Grace Davison Discovery Sciences) (semi-prep) on a Varian Liquid Chromatography System (Varian, Walnut Creek, CA) consisting of Varian ProStar 210 pumps and a ProStar 330 photodiode array detector. Electrospray ionization-mass (ESI-MS) spectra were acquired on an IonSpec HiResMALDI FT-Mass spectrometer with a 7 tesla superconducting magnet. 1 H and 13 C NMR spectra were recorded at 25°C on a Varian Unity Inova 500 instrument operating at 500 MHz for 1 H and 125 MHz for 13 C nuclei. UV-Vis spectrophotometry was performed on a NanoDrop (Thermo-Fisher Scientific).
DNA isolation, manipulation, and development of a genetic system for S. sp. YIM56141.
DNA isolations and manipulations in E. coli and Streptomyces were carried out according to standard procedures. 2 For Southern analysis, digoxigenin labeling of DNA probes, hybridization, and detection were performed according to the protocols provided by the manufacturer (Roche Diagnostics Corp., Indianapolis, IN, USA). E. coli-S. sp. YIM56141 conjugation was carried out using standard literature conditions with the following minor modifications: (i) S. sp. YIM56141 spores in 2 x YT medium were first incubated at 50°C for 10 min followed by 3 hrs at 28°C before mixing with the E. coli ET12567/pUZ8002 donors and (ii) the resultant mixed culture was grown on IWL4 medium. The plates were incubated for 18 hrs at 28°C before they were overlaid with 1 ml H 2 O containing final concentrations of 25 μg/ml trimethoprim (to select against E. coli) and 50 μg/ml apramycin (to select for exconjugants). The plates were incubated for 3-6 days at 28°C. The resultant colonies were replica-plated to isolate the apramycin-resistant and kanamycin-sensitive clones that had undergone double crossover homologous recombination to replace the targeted gene.
Cloning, sequencing, and annotation of the chx gene cluster
A cosmid library of S. sp. YIM56141 chromosomal DNA was constructed by partial digestion with Sau3AI, dephosphorylation, and ligation into the BamHI site of SuperCos1. The ligation mixture was packaged with Gigapack III XL packaging extract and transduced into E. coli XL1 Blue MR cells. Based on the studies of the mgs biosynthetic gene cluster, mgsC, mgsD, and mgsE were proposed to participate in the formation of glutarimide moiety. 6 Using degenerate primers designed according to known mgsC, mgsD and mgsE genes, a fragment of partial putative chxC, chxD and chxE was amplified by PCR from S. sp. YIM56141 using primers p8 and p10 (Table S1 ) and sequenced. A 1.67-kb fragment of chxD and chxE was then amplified by PCR from S. sp. YIM56141 using primers p9 and p10 (Table S1 ) and digoxigenin labeled as a probe. The genomic library was screened by colony hybridization with the probe, and positive clones were confirmed by end sequencing. Two overlapping cosmids (pBS19001 and pBS19002) (Table S2 ) were chosen for sequencing. A subclone library was constructed by inserting cosmid fragments of between 1-5 kb into pUC18, which were then sequenced by ABI 3730XL DNA analyzer (Applied Biosystems, Foster City, CA). ORF assignments, sequence alignments, and identity and similarity calculations were made with the assistance of ORF finder, glimmer, and BLAST from NCBI websites, respectively.
λ-RED-mediated PCR-targeting gene inactivation and complementation
Construction of the mutants. Seven genes [chx-orf(-1), chxE, chxG, chxH, chxI, chxJ, chx-orf1], located on pBS19001 and pBS19002 for the chx cluster, were inactivated in S. sp. YIM56141 by following the λ-RED-mediated PCR-targeting mutagenesis method. 1 Thus, each of the targeted genes was replaced by the aac(3)V-oriT cassette from pIJ773 via λ-RED-mediated PCRtargeting strategy, using orf(-1)-delF and orf(-1)-delR, orf1-delF and orf1-delR, chxE-delF and chxE-delR, chxJ-delF and chxJ-delR, chxI-delF and chxI-delR, chxG-delF and chxG-delR, and chxH-delF and chxH-delR (Table S1) , to yield pBS19003, pBS19004, pBS19005, pBS19006, pBS19008, pBS19010 and pBS19012 (Table S2) , respectively. Each of the mutant constructs was confirmed by PCR using primer pairs orf(-1)-CF and orf(-1)-CR, orf1-CF and orf1-CR, chxE-CF and chxE-CR, chxJ-CF and chxJ-CR, chxI-CF and chxI-CR, chxG-CF and chxG-CR, and chxH-CF and chxH-CR (Table S1 ), respectively.
These mutated cosmids were subsequently introduced into the S. sp. YIM56141 wild-type strain by intergeneric conjugation between S. sp. YIM56141-E. coli ET12567/pUZ8002. Exconjugants with the apramycinresistant and kanamycin-sensitive phenotypes were selected as the desired double crossover mutants. Their genotypes were finally confirmed by Southern analysis (the primers used to prepare the probes for Southern analysis can be found in Table S1 ) (Figures S1, S2, and S4-S8). The correct mutant strains were named SB19001 [Δchx-orf(-1)], SB19002(Δchx-orf1), SB19003 (ΔchxE), SB19004 (ΔchxJ), SB19006 (ΔchxI), SB19008 (ΔchxG), and SB19010 (ΔchxH), respectively (Table S2) .
Complementation of mutants.
For complementation, a derivative of pBS9015 5 was first constructed and named pBS19015, which contained C31 attachment site for site-specific integration, ampicillin and thiostrepton resistance genes for selection, and multiple cloning sites behind the ErmE* promoter 2 to clone the targeted gene whose expression will be ensured under ErmE* (Table S2) . Thus, each of the chxJ, chxI, chxG, and chxH genes was first amplified with primers (see Table S1 ) containing BamHI and XbaI sites. The resulting PCR fragments were then isolated, digested with BamHI and XbaI, and ligated into the same sites of pBS19015 to yield expression plasmids pBS19007 (chxJ), pBS19009 (chxI), pBS19011 (chxG), and pBS19013 (chxH) ( Table S2) .
Introduction of pBS19007, pBS19009, pBS19011, and pBS19013 into SB19004, SB19006, SB19008, and SB19010 by conjugation finally afforded the complementation strains SB19005, SB19007, SB19009, and SB19011, respectively (Table S2) .
HPLC analysis of fermentation extracts
Culture broths of S. sp. YIM56141 wild-type or recombinant strains were extracted with EtOAc and analyzed by a Varian liquid chromatograph system with an Apollo C18 column (5 μm, 250 × 4.6 mm). The column was equilibrated with 100% solvent A (H 2 O) and developed with a 30 min linear gradient from 0% B (acetonitrile) to 100% B and then kept 100% B for 5 min at a flow rate of 1 ml/min and UV detection at 210 nm using a Varian Prostar 330 PDA detector.
Isolation of dehydrocycloheximide (10)
A 5-L fermentation culture (10 x 500 ml in 2-L baffled Erlenmeyer flasks) of mutant SB19010 (ΔchxH) was centrifuged at 3500 x g for 30 min, and the resulting supernatant was extracted with EtOAc twice. The EtOAc extract was evaporated to dryness, and the residue was dissolved in a mixture of CHCl 3 -CH 3 OH (1:1) and mixed with an appropriate amount of silica gel. The sample was applied to a normal phase silica gel column and subsequently eluted with CHCl 3 -CH 3 OH (10:0-8:2) to afford six fractions, each of which was analyzed by HPLC. The fractions that contained 10 were combined, and the compound was finally purified by Varian liquid chromatograph system with an Alltima-C18 column (5 μm, 10 mm x 25 cm). The column was equilibrated with 60% solvent A (H 2 O) and 40% solvent B (acetonitrile) and developed with 40% B for 7 min then change to 55% B for 5 min, finally kept 40% B for 6 min at a flow rate of 3 mL min -1 and UV detection at 280 nm using a Varian Prostar 330 PDA detector. Structural characterization of 10 can be found in Figure S9 and Table S4 .
Cloning and expression of chxH and overproduction and purification of ChxH
The 789bp chxH gene was PCR-amplified from cosmid pBS19002 with primers ChxH-RSF-F and Chx-RSF-R. The PCR reaction was carried out using the Expand High Fidelity PCR System (Roche Diagnostics). Reactions (20 μL) contained 2 μL 10x PCR buffer with MgCl 2 , 2 μl dNTPs (2.5 mM), 1 μl sense primer (10 μM), 1 μl anti-sense primer (10 μM), 1 μl dimethylsulfoxide (DMSO), 1 μl pBS19002 DNA (20 ng), 0.3 μl Taq (3.5 U/μl), and 11.7 μl H 2 O. The following PCR program was used: 95°C 4 min, 30 cycles of 95°C, 30 s, 54°C, 40 s, 72°C, 1 min, and a final extension cycle at 72°C, 10 min. Then PCR product with the expected size was recovered from the agarose gel with a Qiagen gel extraction kit. The fragment was introduced into pBS3080 as described previously to yield plasmid pBS19014. 4 The plasmid pBS19014 was introduced to E. coli BL21 (DE3) to yield SB19012, which was confirmed by DNA sequencing. For chxH expression, a starter culture of SB19012 was grown overnight at 37°C with shaking at 250 rpm in 5 ml of LB media containing 50 g/l of kanamycin. The starter culture was inoculated into 500 ml of LB media containing 50 g/l of kanamycin, and the culture was grown at 37°C with shaking at 250 rpm until it reached an A 600 of 0.6, at which time the culture was cooled to 18°C and IPTG was added to a final concentration of 0.25 mM; the induced culture was left shaking overnight. The cells were harvested by centrifugation and resuspended in lysis buffer (100 mM Tris pH 8.0, 15 mM imidazole, 300 mM NaCl, 10 % glycerol). The cells were then lysed by sonication and the resulting lysate was clarified by centrifugation at 17000 g for 30 min. The lysate was loaded onto a 5 ml HisTrapFF column (GE lifesciences), washed with two column volumes of wash buffer (100 mM Tris pH 8.0, 15 mM imidazole, 300 mM NaCl), and eluted with 50% elution buffer (100 mM Tris pH 8.0, 500 mM imidazole, 300 mM NaCl, 10 % glycerol). Fractions containing ChxH were pooled and buffer exchanged using a PD10 column (GE lifesciences) with 100 mM NaH 2 PO 4 (pH 7.2), 10% glycerol. Protein concentrations were determined using the Bradford method. The resulting protein was near homogeneity based on SDS-PAGE analysis ( Figure S11 ) and stored at -80°C.
In vitro assay and kinetic analysis of ChxH activity
The activity of ChxH was examined at different time points, pH values (pH 5.8-8.0), and concentrations of DMSO. The assay buffer consisted of 100 mM sodium phosphate, 1 mM TCEP, 0.5 mM substrate (suspended in DMSO), 0.5 mM NADPH in a final volume of 100 μl, and the reaction was initiated by addition of ChxH to 0.2 μM, which were allowed to proceed for 10 min at 24°C. Then the reactions were quenched by adding 200 μl MeOH and centrifuged at 13,000g for 10 min, and 100 μl of supernatant was subjected to HPLC analysis. Analytical HPLC was conducted using a Alltima C18 column (250 × 4.6 mm, 5 μm) and eluted with a linear gradient of 60 % water and 40 % acetonitrile for 7 min, then to 45 % water and 55 % acetonitrile for 5 min, followed by 6 min at 60 % water and 40 % acetonitrile at a flow rate of 1.0 mL/min with UV detection at 215 nm. The optimal pH and DMSO concentration was found to be pH 7.2 and 5 % respectively ( Figure S11 ).
The kinetics of ChxH was measured by the decrease or increase in absorbance at 340 nm using an extinction coefficient of 6220 M 
For amplification of the putative chxC, chxD and chxE genes from S. sp. YIM56141 to prepare the probe to clone the chx cluster Oligonucleotide Sequence p8
For amplification of mutated plasmids Plasmid Oligonucleotide Sequence pBS19003
For amplification of probes to confirm each mutant by Southern analysis
For amplification of genes to construct each of the expression plasmids for complementation Plasmid Oligonucleotide Sequence (the BamHI and XbaI sites highlighted in bold) pBS19007
For amplification of genes for heterologous expression Plasmid Oligonucleotide Sequence (highlighted in bold are sequences used for ligation independent cloning) pBS19014 chxH-RSF-F 5'-AAAACCTCTATTTCCAGTCGACGGAGAACAGCCGCAC-3' chxH-RSF-R 5'-TACTTACTTAAATGTTATCAGCACAGGCTCGCGGTCTTCC-3' The sequence has been deposited in GenBank with the accession number JX014302. 
